EnBio Holdings,IncJP:6092
Market cap
¥4.8B
P/E ratio
6.7x
| 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Depreciation & amortization | 7 | 40 | 175 | 331 | 493 | 419 | 359 | 334 | 392 | 431 | 480 |
| Cash from operations | -47 | -419 | 170 | 791 | -391 | 952 | 297 | 2,413 | 1,989 | 1,663 | 22 |
| Capital expenditures | -1,234 | -1,389 | -2,670 | -4,641 | -627 | -357 | -1,729 | -1,165 | -1,163 | -1,079 | -1,462 |
| Cash from investing | -1,501 | -1,538 | -3,955 | -4,613 | -638 | 3,868 | -2,160 | -1,481 | -1,770 | -1,584 | -1,603 |
| Payments for dividends | - | - | - | - | - | - | - | - | -53 | -53 | -65 |
| Repurchases of common stock | - | - | - | - | - | - | - | -44 | - | - | -35 |
| Proceeds from issuance of term debt, net | 1,325 | 1,712 | 3,276 | 6,022 | 1,246 | 876 | 3,084 | 1,540 | 1,350 | 1,987 | 2,529 |
| Repayments of term debt | -244 | -153 | -600 | -1,487 | -1,899 | -4,397 | -1,578 | -1,649 | -1,208 | -2,498 | -1,907 |
| Cash from financing | 1,528 | 2,845 | 3,038 | 5,813 | -154 | -4,062 | 929 | -535 | 241 | 639 | 1,274 |